Lisa Asfahani
Physician Assistant · Riverside, CANPI 1902175623
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by AbbVie at 50.8% of the total. 2025 is the largest year on record at $14,976, more than ten times the $530 reported in 2021. Among physician assistant clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 723 payments — averaging $34.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$12K
- Amgen$2K
- Johnson & Johnson$2K
- UCB, Inc.$2K
- Mallinckrodt Hospital Products Inc.$1K
- GSK$1K
- plus $4K from 22 others
What the payments were for
- Consulting fees$1,1255%
- Speaking & faculty fees$6,30026%
- Travel & lodging$2,67411%
- Food & beverage$14,27058%
- Education$2131%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 189 | $12,500 |
| Amgen(2 entities) | 117 | $2,157 |
| Johnson & Johnson(2 entities) | 87 | $1,634 |
| UCB, Inc. | 68 | $1,561 |
| Mallinckrodt Hospital Products Inc. | 11 | $1,207 |
| GSK | 48 | $1,156 |
| Novartis | 51 | $936 |
| Aurinia Pharma U.S., Inc. | 32 | $715 |
| Lilly USA, LLC | 25 | $599 |
| Pfizer | 23 | $456 |
| ANI Pharmaceuticals, Inc. | 12 | $300 |
| Boehringer Ingelheim | 12 | $298 |
| AstraZeneca(2 entities) | 8 | $149 |
| Genentech USA, Inc. | 5 | $133 |
| Alvogen Inc | 6 | $115 |
| Radius Health, Inc. | 5 | $107 |
| Kyowa Kirin, Inc. | 5 | $101 |
| Sanofi | 4 | $86 |
| E.r. Squibb & Sons, L.L.C. | 2 | $68 |
| Sandoz | 3 | $63 |
| Octapharma USA, Inc. | 2 | $48 |
| Cumberland Pharmaceuticals, Inc. | 1 | $43 |
| Fidia Pharma USA Inc. | 2 | $37 |
| Fresenius Kabi USA, LLC | 1 | $34 |
| Sobi, Inc | 1 | $28 |
| Vertex | 1 | $23 |
| Tonix Medicines, Inc. | 1 | $16 |
| Vertos Medical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$24,582 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RinvoqUpadacitinib | 49 | $345,559 |
| Humira(Cf) PenAdalimumab | 33 | $267,956 |
| ProliaDenosumab | 59 | $100,706 |
| Enbrel SureclickEtanercept | 11 | $84,376 |
| Xeljanz XrTofacitinib Citrate | 14 | $77,705 |
| Teriparatide | 20 | $65,058 |
| Actemra ActpenTocilizumab | 14 | $60,263 |
| BenlystaBelimumab | 20 | $48,835 |
| Hydroxychloroquine Sulfate | 379 | $18,344 |
| Cevimeline Hcl | 26 | $5,973 |
| MethotrexateMethotrexate Sodium | 227 | $5,562 |
| Zoledronic AcidZoledronic Acid/Mannitol-Water | 19 | $3,801 |
| Colchicine | 37 | $3,687 |
| Mycophenolate Mofetil | 29 | $2,595 |
| Pilocarpine Hcl | 17 | $1,762 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $12,500 | $345,55949 claims |
| AmgenProlia | $2,157 | $100,70659 claims |
| Alvogen IncTeriparatide | $115 | $65,05820 claims |
| GSKBenlysta | $1,156 | $48,83520 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Riverside
- Sheila Anne BobisRiverside$55K
- Robert FontanillaRiverside$32K
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.